Malcolm Macartney
Impact in
- Virology top 1%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 6
- HIV/AIDS Research and Interventions 3
- Virology 6
- HIV Research and Treatment 6
- Co-authors
- Paul Griffin (2 shared papers)Patrick Dorr (2 shared papers)Mike Westby (2 shared papers)Manos Perros (2 shared papers)Carolyn Napier (2 shared papers)Blanda Stammen (1 shared paper)Anthony Wood (1 shared paper)Rob Webster (1 shared paper)
- Journals
- Journal of Clinical Virology (2 papers)Journal of Medical Virology (2 papers)Influenza and Other Respiratory Viruses (1 paper)Antiviral Research (1 paper)SpringerPlus (1 paper)
- Partner nations
- United KingdomUnited StatesBelgium
In The Last Decade
Malcolm Macartney
18 papers receiving 1.1k citations
Malcolm Macartney's Hit Papers
Peers
Comparison fields: 5 of 80
- Virology 604
- Infectious Diseases 421
- Hepatology 91
- Immunology 180
- Epidemiology 179
Countries citing papers authored by Malcolm Macartney
This map shows the geographic impact of Malcolm Macartney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malcolm Macartney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malcolm Macartney more than expected).
Fields of papers citing papers by Malcolm Macartney
This network shows the impact of papers produced by Malcolm Macartney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malcolm Macartney. The network helps show where Malcolm Macartney may publish in the future.
Co-authors
The 25 scholars most cited alongside Malcolm Macartney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity Hit paper breakdown → | 2005 | 910 |
| 2 | 2023 | 47 | |
| 3 | 1997 | 21 | |
| 4 | 2015 | 14 | |
| 5 | 2009 | 13 | |
| 6 | 2023 | 12 | |
| 7 | 2014 | 12 | |
| 8 | 2014 | 10 | |
| 9 | 2015 | 8 | |
| 10 | 2016 | 6 | |
| 11 | 2014 | 5 | |
| 12 | 2013 | 5 | |
| 13 | 2018 | 4 | |
| 14 | 2003 | 4 | |
| 15 | 1999 | 2 | |
| 16 | 2014 | 1 | |
| 17 | Anaplasmosis in a dog on Vancouver Island. | 2015 | 1 |
| 18 | 2014 | 1 | |
| 19 | 2024 | 0 |
About Malcolm Macartney
Malcolm Macartney is a scholar working on Infectious Diseases, Virology, Epidemiology, Hepatology and Surgery, having authored 19 papers that have together received 1.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (6 papers), Hepatitis C virus research (5 papers), Hepatitis B Virus Studies (3 papers), HIV/AIDS Research and Interventions (3 papers), Cytomegalovirus and herpesvirus research (2 papers), Botany, Ecology, and Taxonomy Studies (1 paper) and Hepatitis Viruses Studies and Epidemiology (1 paper). The work is most often cited by research in Virology (604 citations), Infectious Diseases (421 citations), Hepatology (91 citations), Immunology (180 citations) and Epidemiology (179 citations). Malcolm Macartney has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include Paul Griffin, Patrick Dorr, Mike Westby, Manos Perros, Carolyn Napier, Blanda Stammen, Anthony Wood, Rob Webster, Duncan Armour and Julie Mori. Their work appears in journals such as Journal of Clinical Virology, Journal of Medical Virology, Influenza and Other Respiratory Viruses, Antiviral Research and SpringerPlus.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.